Bone marrow suppression in pediatric patients with differentiated thyroid cancer following empirical radioiodine therapy

Pediatric patients with differentiated thyroid cancer (DTC) tend to have more advanced disease at presentation, for which more aggressive radioiodine (RAI) treatment would be commonly recommended. Several previous studies recommended dosimetry to calculate the optimal activity of RAI in pre-pubertal...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Ping, Wang, Li, Huang, Rui, Li, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402880/
https://www.ncbi.nlm.nih.gov/pubmed/32756134
http://dx.doi.org/10.1097/MD.0000000000021398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402880/
https://www.ncbi.nlm.nih.gov/pubmed/32756134
http://dx.doi.org/10.1097/MD.0000000000021398

Ejemplares similares